OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2008
(3)
2025
(2)
2024
(2)
2023
(2)
2022
(1)
2021
(1)
2018
(1)
2016
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Triterpenoid and Coumarin Isolated from
Astilbe grandis
with Anti-Inflammatory Effects through Inhibiting the NF-κB Pathway in LPS-Induced RAW264.7 Cells.
Not available
S-EPMC10421095
|
biostudies-literature
Cite
Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.
Not available
S-EPMC4245039
|
biostudies-literature
Cite
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774
|
biostudies-literature
Cite
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients.
Not available
S-EPMC6807207
|
biostudies-literature
Cite
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury.
Not available
S-EPMC12095075
|
biostudies-literature
Cite
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry.
Not available
S-EPMC10869374
|
biostudies-literature
Cite
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Not available
S-EPMC2772657
|
biostudies-literature
Cite
Telmisartan to prevent recurrent stroke and cardiovascular events.
Not available
S-EPMC2714258
|
biostudies-literature
Cite
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Not available
S-EPMC2714259
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets